A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care
Clinical trial NCT06693531 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06693531
- Sponsor
- Regeneron Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-11-22
- Primary completion
- 2030-05-22
- Enrollment
- 368
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.